SR-1 (Stanford University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSR-1 (Stanford University)
Drug Alias Nameanti-KIT antibody (Stanford University)anti-CD117 antibody (Stanford University)SR-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford University
Active IndicationsN/A
Inactive IndicationsGastrointestinal Stromal Tumors

Other Information

ATC CodeN/A
Related LinksN/A